Natural Products and their Analogues as Efficient Anticancer Drugs

被引:84
作者
Coseri, Sergiu [1 ]
机构
[1] Petru Poni Inst Macromol Chem, Iasi 700487, Romania
关键词
Anticancer; natural products; pancreatic cancer; gastric cancer; breast cancer; colon cancer; leukemia; PHOSPHOINOSITIDE 3-KINASE INHIBITORS; SANSALVAMIDE-A DERIVATIVES; BREFELDIN-A; SULFIDE DERIVATIVES; DESOXYEPOTHILONE B; PRODRUG CANDIDATES; ANTHRANILIC ACID; SOLID-PHASE; BIOSYNTHESIS; GOSSYPOL;
D O I
10.2174/138955709788167592
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Every year about 7 million people die from of various types of cancer, making this disease responsible for 12.5% of deaths worldwide. Consequently, there is an overwhelming demand to develop new, more potent and effective, anticancer drugs. Natural products represent the most valuable source with inexhaustible reserves, in which the researchers work could identify novel active agents that may serve as the leads and scaffolds for transformation into desperately needed efficacious drugs. This paper is devoted to reviewing some of the most outstanding achievements in the application of natural products as models and precursors for anticancer agents published in the post 2000 literature. Particular emphasis is placed on the chemical modification of active principles isolated from natural products, in hope of obtaining the desirable derivatives for the treatment of different types of cancer, including pancreatic, gastric, breast, colon cancers and leukemia.
引用
收藏
页码:560 / 571
页数:12
相关论文
共 100 条
[1]   Terpenoids: Opportunities for biosynthesis of natural product drugs using engineered microorganisms [J].
Ajikumar, Parayil Kumaran ;
Tyo, Keith ;
Carlsen, Simon ;
Mucha, Oliver ;
Phon, Too Heng ;
Stephanopoulos, Gregory .
MOLECULAR PHARMACEUTICS, 2008, 5 (02) :167-190
[2]   Cl-1040 (PD184352), a targeted signal transduction inhibitor of MEK (MAPKK) [J].
Allen, LF ;
Sebolt-Leopold, J ;
Meyer, MB .
SEMINARS IN ONCOLOGY, 2003, 30 (05) :105-116
[3]   Synthesis and anticancer activity of brefeldin A ester derivatives [J].
Anadu, Nwanne O. ;
Davisson, V. Jo ;
Cushman, Mark .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (13) :3897-3905
[4]  
[Anonymous], 1978, Chin Med J (Engl), V4, P417
[5]   Design and synthesis of brefeldin A sulfide derivatives as prodrug candidates with enhanced aqueous solubilities [J].
Argade, AB ;
Devraj, R ;
Vroman, JA ;
Haugwitz, RD ;
Hollingshead, M ;
Cushman, M .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (18) :3337-3346
[6]   Sansalvamide: A new cytotoxic cyclic depsipeptide produced by a marine fungus of the genus Fusarium [J].
Belofsky, GN ;
Jensen, PR ;
Fenical, W .
TETRAHEDRON LETTERS, 1999, 40 (15) :2913-2916
[7]   EFFECT OF GOSSYPOL UPON MOTILITY AND ULTRASTRUCTURE OF TRYPANOSOMA-CRUZI [J].
BLANCO, A ;
AOKI, A ;
MONTAMAT, EE ;
ROVAI, LE .
JOURNAL OF PROTOZOOLOGY, 1983, 30 (04) :648-651
[8]   KINETIC-STUDIES ON 2',2'-DIFLUORODEOXYCYTIDINE (GEMCITABINE) WITH PURIFIED HUMAN DEOXYCYTIDINE KINASE AND CYTIDINE DEAMINASE [J].
BOUFFARD, DY ;
LALIBERTE, J ;
MOMPARLER, RL .
BIOCHEMICAL PHARMACOLOGY, 1993, 45 (09) :1857-1861
[9]  
Breitmaier E, 2006, Appl. Organometal. Chem.
[10]   Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial [J].
Burris, HA ;
Moore, MJ ;
Andersen, J ;
Green, MR ;
Rothenberg, ML ;
Madiano, MR ;
Cripps, MC ;
Portenoy, RK ;
Storniolo, AM ;
Tarassoff, P ;
Nelson, R ;
Dorr, FA ;
Stephens, CD ;
VanHoff, DD .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (06) :2403-2413